INTRODUCTION
============

Diabetes mellitus (DM) is a common progressive metabolic disease that may lead to complications such as retinopathy, neuropathy, nephropathy, cardiovascular disease, and osteoporosis. Diabetic complications are major public health problems and are increasing in prevalence worldwide ([@b1-pnfs-24-121]). Fragility fractures have increasingly been recognized as a complication of both type 1 and 2 diabetes mellites (T1DM and T2DM, respectively) ([@b10-pnfs-24-121]), and are the leading cause of morbidity and mortality in older adults with diabetes ([@b4-pnfs-24-121]). Low bone mineral density (BMD) is a risk factor of fragility fractures; BMD has been shown to decrease in T1DM, and to both decrease and increase in T2DM as compared healthy individuals ([@b28-pnfs-24-121]; [@b30-pnfs-24-121]). Moreover, anti-diabetic medications, such as thiazolidinediones and sodium glucose cotransporter 2 inhibitors, have been shown to induce diabetic bone disorders via effects on bone and mineral metabolism ([@b29-pnfs-24-121]; [@b27-pnfs-24-121]; [@b11-pnfs-24-121]). Recently, natural plants have attracted a great deal of interest as sources of alternative medicines for prevention and treatment of diabetes-related bone disorders.

*Polygonum multiflorum* Thunb. is a popular Chinese traditional medicinal herb, which is known as Heshouwu in China, Korea, and East Asia, and as Fo-ti in North America ([@b3-pnfs-24-121]). Heshouwu has a low toxicity and exhibits various pharmacological activities, such as anti-tumor ([@b15-pnfs-24-121]; [@b8-pnfs-24-121]), anti-inflammation ([@b5-pnfs-24-121]), nephroprotective ([@b12-pnfs-24-121]), anti-atherosclerosis ([@b33-pnfs-24-121]; [@b34-pnfs-24-121]), and anti-diabetes ([@b18-pnfs-24-121]) activities. We previously showed that Heshouwu ethanol extract attenuates hyperglycemia and hyperinsulinemia in diet-induced obese mice ([@b7-pnfs-24-121]). [@b16-pnfs-24-121] and [@b22-pnfs-24-121] reported that Heshouwu hot water extract and tetrahydroxystilbene glucoside (THSG), which is a bioactive compound of Heshouwu, prevent bone loss in estrogen deficient mice. [@b35-pnfs-24-121] recently reported that THSG protects against diabetes-induced osteoporosis in mice with streptozotocin (STZ)-induced diabetes. However, it remains unknown if Heshouwu can regulate diabetes-induced bone loss *in vivo*, or the mechanism by which its effects occur. Therefore, we investigated the effects of Heshouwu water extract (HSW) on serum bone-related markers, BMD, bone quality parameters and bone metabolism-related gene levels in high-fat diet (HFD) and STZ-induced diabetic mice.

MATERIALS AND METHODS
=====================

Heshouwu (*Polygonum multiflorum* Thunb.) extract
-------------------------------------------------

Heshouwu (500 g) (Dong-Bu Herbal Makers, Suncheon, Korea) were extracted three times with water (each 5 L) by exhaustive maceration under sonication at 85°C for 3 h. The supernatant was filtered using Whatman number 2 filter paper (Whatman, Kent, England). The extracted fluid was concentrated with a rotary evaporator (EYELA, Tokyo, Japan) and freeze-dried to yield crude extract (25.2%).

Animal experiment
-----------------

Male four-week-old C57BL/6N mice were purchased from Orient Bio Inc. (Seongnam, Korea). The animals were individually housed in polycarbonate cages and maintained in a temperature and humidity-controlled room (22±2 °C, 50±5% humidity) under a 12-h light-dark cycle. This study was approved by the Institutional Animal Care and Use Committee of Sunchon National University (approval number, SCNU IACUC-2016-11). All mice were acclimatized for 7 days, then fed HFD (40% calories from fat) for 4 weeks. After the HFD feeding period, mice were intraperitoneally injected with STZ (100 mg/kg body weight) dissolved in 0.1 M citrate buffer at pH 4.2 for 2 consecutive days. Only mice that exhibited a fasting blood glucose (FBG) level ≥ 250 mg/dL after 7 days were used in the study. The diabetic mice were randomly divided into two groups of eight mice each (control and HSW-treated group). In the present study, HSW was orally administered at 300 mg/kg body weight for 10 weeks, as described previously ([@b9-pnfs-24-121]).

During the experimental period, blood glucose levels and body weight were measured weekly and food consumption was measured daily. At the end of the experimental period, mice were anesthetized with ether and sacrificed after 12 h of fasting to collect blood and tissue samples for analysis. Blood samples were collected from the inferior vena cava and centrifuged (3,000 rpm for 15 min at 4°C) to separate out the serum. Tissues (liver, kidney, heart, and bone) were removed, rinsed with an ice-cold physiological saline solution, and weighed.

Micro-computed tomography (μCT) analysis
----------------------------------------

For μCT analysis of bone tissues (femurs and tibias), samples were isolated, cleaned of adherent soft tissues, and kept in 70% ethyl alcohol solution until scanning. To prevent moisture infiltrating, samples were wrapped with plastic wrap and placed into a holder. Morphometric parameters of bone samples were assessed using a μCT system (Skyscan 1272, Bruker, Kontich, Belgium). The scan setting were as follows: voltage of 70 kV, current of 142 μA, resolution step of 26.5 μm, and rotation step of 0.4°. 2D images were obtained for visualization and display. The image slices were reconstructed and analyzed using NReacon and CTAn (version 1.16.4.1, Bruker) software. BMD, bone volume/tissue volume ratio (BV/TV), bone surface/bone volume ratio (BS/BV), trabecular number (Tb.N), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp), and structure model index (SMI) were then calculated. For quantification of trabecular BMD, the μCT was calibrated using two standard phantoms with a density of 0.25 and 0.75 g/cm^3^. The distal femur and tibia metaphysic represented regions of interest for analysis.

Blood glucose, glycosylated hemoglobin (HbA~1c~), serum insulin, and bone markers
---------------------------------------------------------------------------------

The FBG concentration was monitored using a glucometer (G-doctor, AllMedicus Co., Ltd., Anyang, Korea). Venous blood was drawn from the tail vein every week after a six-hour fast, and the HbA~1c~ concentration in whole blood was measured using a NycoCard Reader II (Alere/Axis-Shield, Oslo, Norway). Serum insulin (Morinaga Institute of Biological Science, Yokohama, Japan), osteocalcin (OCN, Elabscience, Wuhan, China), bone-alkaline phosphatase (BAP, Elabscience), and tartrate-resistant acid phosphatase 5 (TRAP) (Cusabio Biotech, Wuhan, China) levels were determined using mouse enzyme-linked immunosorbent assay kits.

Quantitative polymerase chain reaction analysis
-----------------------------------------------

Total RNA isolation from bone tissue and mRNA expression (*NFATc1*: nuclear factor of activated T-cells, cytoplasmic 1, *RANKL*: receptor activator of nuclear factor kappa-B ligand, and *TRAP*) analysis were conducted as previously described ([@b13-pnfs-24-121]). The sequences of the primers used are shown in [Table 1](#t1-pnfs-24-121){ref-type="table"}. Gene expression was normalized against the β*-actin* gene.

Statistical analysis
--------------------

All data are expressed as the mean±standard error (SE). The SPSS program was used to conduct all statistical analyses (SPSS Inc., Chicago, IL, USA). Data between groups were compared by Student's *t*-test. Correlations between serum insulin levels and BMD were assessed by Pearson's correlation analysis. A *P*\<0.05 was considered statistically significant for all analyses.

RESULTS AND DISCUSSION
======================

Effects of HSW on blood glucose, HbA~1c~, and insulin level
-----------------------------------------------------------

This study showed that HSW suppressed increases in FBG levels throughout the experimental period in HFD and STZ induced-diabetic mice; FBG levels were significantly lower (21%) in HSW mice compared with control mice at week 10 ([Fig. 1A](#f1-pnfs-24-121){ref-type="fig"}). THSG extracted from HSW has been shown to have hypoglycemic effects and to protect against nephropathy in mice and rats ([@b23-pnfs-24-121]; [@b6-pnfs-24-121]; [@b36-pnfs-24-121]). HbA~1c~ levels reflect average blood glucose levels over the past 2\~3 months ([@b19-pnfs-24-121]); we therefore measured HbA~1c~ levels in the present study. Although not statistically significant, HSW-administered mice showed a decrease in HbA~1c~ levels approximately 10.4% ([Fig. 1B](#f1-pnfs-24-121){ref-type="fig"}). Since long-term hyperglycemia decreases body weight and insulin levels, we measured the effects of HSW on these parameters. The results demonstrated that HSW prevented body weight loss and increased serum insulin levels ([Fig. 1C, D](#f1-pnfs-24-121){ref-type="fig"}, and [Table 2](#t2-pnfs-24-121){ref-type="table"}); however, HSW did not affect the weight of organs (liver, kidney and heart) or food intake ([Table 2](#t2-pnfs-24-121){ref-type="table"}). Thus, these results indicate that HSW might exert anti-diabetic effects by increasing insulin levels.

Effects of HSW on microarchitecture and serum markers of bone conversion
------------------------------------------------------------------------

Diabetic patients have a higher risk of bone fractures ([@b17-pnfs-24-121]). Because our coworkers previously indicated that HSW hot water extract and its bioactive component THSG prevent bone loss in an ovariectomy-induced osteoporosis mouse model ([@b16-pnfs-24-121]; [@b22-pnfs-24-121]), this study was conducted to determine if HSW extract may prevent bone loss caused by diabetes.

Osteoporosis is characterized by low bone mass and microstructural damage of the bone tissue ([@b24-pnfs-24-121]). Two dimensional μCT images of femoral and tibial trabecular and cortical bones revealed greater bone densities in the HSW group than the control group ([Fig. 2A](#f2-pnfs-24-121){ref-type="fig"}). BMD is the major quantitative indicator of osteoporosis ([@b24-pnfs-24-121]). In the present study, HSW significantly increased femoral BMD by 1.8-fold and tended to increase the tibial BMD by 1.3-fold compared to the control group ([Fig. 2B](#f2-pnfs-24-121){ref-type="fig"}). Interestingly, we found that serum insulin levels were positively associated with the BMD in the femur (r=0.690, *P*\<0.001) and tibia (r=0.569, *P*\<0.05), respectively ([Fig. 2C](#f2-pnfs-24-121){ref-type="fig"}). Compared with the control group, HSW significantly increased the BV/TV, Tb.Th, and Tb.N, and decreased the BS/BV and SMI ([Fig. 3](#f3-pnfs-24-121){ref-type="fig"}). In addition, HSW significantly decreased Tb.Sp in the femur ([Fig. 3](#f3-pnfs-24-121){ref-type="fig"}). Diabetes induces trabecular microarchitecture deterioration resulting in thinner and more rod-like trabeculae (higher SMI), which are more prone to bending deformation ([@b2-pnfs-24-121]). Here, we found that HSW induced thicker, more plate-like trabeculae, and increased their numbers, indicating that bone strength was increased relative to the control group. These results suggest that HSW might increase bone mass and alleviate the trabecular microstructure in diabetic mice, while increasing insulin levels.

To confirm the anti-osteoporosis effects of HSW, we evaluated serum bone-related biochemical indexes. Compared with the control group, in the HSW group serum OCN and BAP were increased, and TRAP was decreased ([Table 3](#t3-pnfs-24-121){ref-type="table"}). OCN plays a key role in mineralization and may be essential for osteoblast differentiation ([@b14-pnfs-24-121]). [@b17-pnfs-24-121] reported that OCN directly stimulates insulin secretion in the pancreas, which may be an important factor linking bone and glucose homeostasis. BAP is also an important marker of bone formation and bone turnover, and is used in the evaluation of skeletal status ([@b25-pnfs-24-121]). In contrast, the increased TRAP in diabetic rats reflects a trend toward bone loss ([@b31-pnfs-24-121]; [@b26-pnfs-24-121]). Thus, HSW increases the bone formation markers OCN and BAP, and suppresses the bone resorption marker TRAP in diabetic mice.

Effects of HSW on bone metabolism-related gene expression
---------------------------------------------------------

We investigated the effect of HSW on bone formation and resorption-related gene expression. The results revealed that HSW significantly down-regulated osteoclastogenic genes, such as *NFATc1* and *TRAP*, in both the femur and tibia compared to the control group ([Fig. 4](#f4-pnfs-24-121){ref-type="fig"}). Bone remodeling is regulated by the balance between bone formation (osteoblasts) and bone resorption (osteoclasts) ([@b32-pnfs-24-121]). Loss of this homeostasis leads to bone diseases such as osteoporosis, rheumatoid arthritis, and osteosarcoma. Osteoclasts are bone resorbing cells that are differentiated from the hematopoietic stem cells monocyte/macrophage lineage by RANKL ([@b21-pnfs-24-121]). In the present study, HSW decreased *RANKL* mRNA levels in the femur (52.8%) and tibia (31.2%) compared controls, although this decrease was only significant in the femur ([Fig. 4](#f4-pnfs-24-121){ref-type="fig"}). Binding of RANKL to its receptor on the surface of osteoclast precursor cells induces expression of important transcription factors for osteoclastogenesis, such as nuclear factor-κB, c-Fos, and NFATc1 ([@b20-pnfs-24-121]). In particular, *NFATc1* is an indispensable factor for osteoclast differentiation *in vitro* and *in vivo*, which suggests that its regulation could be targeted by novel therapeutic strategies for bone diseases ([@b20-pnfs-24-121]). *NFATc1* controls osteoclast-specific genes, such as *TRAP*, *cathepsin K*, and *calcitonin receptor* ([@b21-pnfs-24-121]). *NFATc1* expression in the femur (r=0.546, *P*\<0.05) and tibia (r=0.622, *P*\<0.05) were negatively correlated with serum BAP levels (data not shown). In the present study, HSW suppressed *NFATc1* expression in the femur and tibia and downstream *TRAP* expression, which corresponded to reduced serum TRAP levels relative to the control. Reducing osteoclast differentiation-associated pathways by HSW may therefore represent a potential method for therapeutic intervention to prevent diabetes-related bone loss. In contrast, a previous study showed that THSG increases osteoblastogenic genes such as *runt-related transcription factor 2* (*RUNX-2*), *OCN*, and *ALP* in STZ-induced diabetic mice ([@b35-pnfs-24-121]). Our data did not show significant changes in *RUNX-2*, *OCN*, and *ALP* between groups (data not shown). In conclusion, these results indicate that HSW might play a protective role in diabetesinduced osteoporosis, in part by down-regulating osteoclastogenesis.
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###### 

Sequences of primers used for real-time PCR

  Genes       Primer sequences (5′ → 3′)   Size (bp)                
  ----------- ---------------------------- ------------------------ -----
  *NFATc1*    Forward                      AGGACCCGGAGTTCGACTT      106
  Reverse     GTCGAGGTGACACTAGGGGA                                  
  *RANKL*     Forward                      CGAGGAAGGGAGAGAACGAT     92
  Reverse     AGGTACTTGCCGTAGTCTCG                                  
  *TRAP*      Forward                      AGGAAGAGCCTTCAAGTAAGTG   89
  Reverse     CCACCCATGAATCCATCTTCT                                 
  *β-Actin*   Forward                      GATCAGCAAGCAGGAGTACGA    91
  Reverse     GGTGTAAAACGCAGCTCAGTAAC                               

*NFATc1*, nuclear factor of activated T-cells, cytoplasmic 1; *RANKL*, receptor activator of nuclear factor kappa-B ligand; *TRAP*, tartrate-resistant acid phosphatase 5.

###### 

Effects of Heshouwu water extract (HSW) on body weight gain, food intake, and relative organ weights in diabetic mice

                                  Control      HSW
  ------------------------------- ------------ --------------------------------------------------------
  Body weight gain (g)            −2.35±0.59   −0.25±0.74[\*](#tfn4-pnfs-24-121){ref-type="table-fn"}
  Food intake (g/d)               3.80±0.08    3.54±0.14
  Relative organ weights (mg/g)                
   Liver                          51.89±2.16   45.85±1.22
   Kidney                         16.52±0.59   15.10±1.90
   Heart                          4.92±0.11    4.66±0.23

Values are expressed as mean±SE.

Values are significantly different between groups according to Student's *t*-test.

*P*\<0.05 versus control.

###### 

Effects of Heshouwu water extract (HSW) on serum bone biomarkers in diabetic mice (unit: ng/mL)

         Control      HSW
  ------ ------------ ----------------------------------------------------------
  OCN    0.87±0.14    4.85±0.60[\*\*](#tfn9-pnfs-24-121){ref-type="table-fn"}
  BAP    0.90±0.27    2.27±0.39[\*](#tfn7-pnfs-24-121){ref-type="table-fn"}
  TRAP   61.27±2.33   49.79±1.14[\*\*](#tfn9-pnfs-24-121){ref-type="table-fn"}

Values are expressed as mean±SE.

Values are significantly different between groups according to Student's *t*-test.

*P*\<0.05 and

*P*\<0.01 versus control.

OCN, osteocalcin; BAP, bone-alkaline phosphatase; TRAP, tartrate-resistant acid phosphatase 5.
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